Neurofilament light chain: a new marker for neuronal decay in the anterior chamber fluid of patients with glaucoma

被引:8
|
作者
Woltsche, Nora [1 ]
Valentin, Katharina [1 ]
Hoeflechner, Lukas [1 ]
Guttmann, Andreas [1 ]
Horwath-Winter, Jutta [1 ]
Schneider, Mona Regina [1 ]
Ivastinovic, Domagoj [1 ]
Lindner, Marlene [2 ]
Schmetterer, Leopold [3 ,4 ]
Singh, Neena [5 ]
Riedl, Regina [6 ]
Buchmann, Arabella [7 ]
Khalil, Michael [7 ]
Lindner, Ewald [1 ]
机构
[1] Med Univ Graz, Dept Ophthalmol, Graz, Austria
[2] Med Univ Graz, Dept Dent, Graz, Steiermark, Austria
[3] Singapore Eye Res Inst, Ocular Imaging, Singapore, Singapore
[4] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria
[5] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
[6] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria
[7] Med Univ Graz, Dept Neurol, Graz, Steiermark, Austria
关键词
Glaucoma; Anterior chamber; Aqueous humour; OPTIC-NERVE HEAD; INTRAOCULAR-PRESSURE; RISK; PROGRESSION; BLINDNESS;
D O I
10.1136/bjo-2021-320828
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/Aims Neurofilament light chain (NfL) levels in cerebrospinal fluid and serum are reliable indicators for neuroaxonal damage in a broad spectrum of neurodegenerative diseases. Herein, we investigate NfL levels in serum and anterior chamber fluid of patients with glaucoma. Methods Patients scheduled for routine glaucoma or cataract surgery were recruited for this study. Retinal nerve fibre layer thickness was measured by optical coherence tomography (OCT, Heidelberg Spectralis). NfL levels in serum and in anterior chamber fluid were analysed with Simoa SR-X Analyzer (Quanterix; NFLIGHT, Lexington, Massachusetts, USA). T-test was used for parametric data and Mann-Whitney-U test for nonparametric data. Spearman's rank-order correlation was used to investigate correlations. P values Results Sixty patients with glaucoma and 58 controls were enrolled. Serum NfL concentration of patients with glaucoma was similar to serum NfL concentration in controls (median (IQR); 22.7 (18.9) pg/mL vs 22.5 (24.0) pg/mL; p=0.763). A positive correlation of serum NfL with age was observed in both patients with glaucoma (r=0.77; p<0.001) and in the control group (r=0.82, p<0.001). In the anterior chamber fluid, the NfL concentration was substantially increased in patients with glaucoma compared with controls (20.7 (101.3) pg/mL vs 3.1 (2.9) pg/mL; p<0.001). Furthermore, we found a positive correlation of anterior chamber fluid NfL with preoperative intraocular pressure (r=0.39, p=0.003) and with retinal nerve fibre layer thickness (r=0.58, p<0.001). Conclusion NfL levels in anterior chamber fluid are elevated in patients with glaucoma and correlate with intraocular pressure and retinal nerve fibre layer thickness. The presented data strongly support anterior chamber fluid NfL as a new marker for glaucoma.
引用
收藏
页码:1432 / 1437
页数:6
相关论文
共 50 条
  • [41] A Case of HaNDL with Low Cerebrospinal Fluid Level of Neurofilament Light Chain
    Sisman, Aysel Busra
    Bayar, Muhammet Duran
    Icoz, Sema
    Yilmaz, Vuslat
    Kurtuncu, Murat
    Tuzun, Erdem
    Ertas, Mustafa
    Bastan, Birgul
    CASE REPORTS IN NEUROLOGY, 2020, 12 (03) : 334 - 338
  • [42] Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia
    Kessler, Christoph
    Serna-Higuita, Lina M.
    Rattay, Tim W.
    Maetzler, Walter
    Wurster, Isabel
    Hayer, Stefanie
    Wilke, Carlo
    Hengel, Holger
    Reichbauer, Jennifer
    Armbruster, Marcel
    Schoels, Ludger
    Martus, Peter
    Schuele, Rebecca
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (05): : 1122 - 1131
  • [43] Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
    Meeter, Lieke H. H.
    Steketee, Rebecca M. E.
    Salkovic, Dina
    Vos, Maartje E.
    Grossman, Murray
    McMillan, Corey T.
    Irwin, David J.
    Boxer, Adam L.
    Rojas, Julio C.
    Olney, Nicholas T.
    Karydas, Anna
    Miller, Bruce L.
    Pijnenburg, Yolande A. L.
    Barkhof, Frederik
    Sanchez-Valle, Raquel
    Llado, Albert
    Borrego-Ecija, Sergi
    Diehl-Schmid, Janine
    Grimmer, Timo
    Goldhardt, Oliver
    Santillo, Alexander F.
    Hansson, Oskar
    Vestberg, Susanne
    Borroni, Barbara
    Padovani, Alessandro
    Galimberti, Daniela
    Scarpini, Elio
    Rohrer, Jonathan D.
    Woollacott, Ione O. C.
    Synofzik, Matthis
    Wilke, Carlo
    de Mendonca, Alexandre
    Vandenberghe, Rik
    Benussi, Luisa
    Ghidoni, Roberta
    Binetti, Giuliano
    Niessen, Wiro J.
    Papma, Janne M.
    Seelaar, Harro
    Jiskoot, Lize C.
    de Jong, Frank Jan
    Kaat, Laura Donker
    Del Campo, Marta
    Teunissen, Charlotte E.
    Bron, Esther E.
    Van den Berg, Esther
    Van Swieten, John C.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (09): : 997 - 1004
  • [44] Evaluating neurofilament light chain serum levels as a diagnostic marker for Lyme neuroborreliosis
    Hirzel, Cedric
    Grutter, Annina
    Grandgirard, Denis
    Hoepner, Robert
    Suter-Riniker, Franziska
    Leib, Stephen L.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2025, 18
  • [45] Cerebrospinal fluid neurofilament light chain as a biomarker for early diagnosis of multiple sclerosis in patients with optic neuritis
    Passali, Moschoula
    Galea, Ian
    Knudsen, Maria Hojberg
    Lau, Laurie
    Cramer, Stig
    Frederiksen, Jette
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 298 - 298
  • [46] Neurofilament light chain levels in cerebrospinal fluid do not discriminate between patients with Prion disease and mimics
    Roeben, B.
    Stransky, E.
    Brockmann, K.
    Schuele, R.
    Maetzler, W.
    Gasser, T.
    Machetanz, G.
    MOVEMENT DISORDERS, 2017, 32
  • [47] Prolonged Cerebrospinal Fluid Neurofilament Light Chain Increase in Patients with Post-Traumatic Disorders of Consciousness
    Bagnato, Sergio
    Grimaldi, Luigi M. E.
    Di Raimondo, Giorgio
    Sant'Angelo, Antonino
    Boccagni, Cristina
    Virgilio, Vittorio
    Andriolo, Maria
    JOURNAL OF NEUROTRAUMA, 2017, 34 (16) : 2475 - 2479
  • [48] Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis
    Gille, B.
    De Schaepdryver, M.
    Goossens, J.
    Dedeene, L.
    De Vocht, J.
    Oldoni, E.
    Goris, A.
    Van Den Bosch, L.
    Depreitere, B.
    Claeys, K. G.
    Tournoy, J.
    Van Damme, P.
    Poesen, K.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2019, 45 (03) : 291 - 304
  • [49] Serum neurofilament light chain as a predictive marker in patients after first demyelinating event suggestive of multiple sclerosis
    Benova, B.
    Barro, C.
    Andelova, M.
    Uher, T.
    Michalak, Z.
    Tyblova, M.
    Kucerova, K.
    Hrnciarova, T.
    Vaneckova, M.
    Kadrnozkova, L.
    Motyl, J.
    Havrdova, E.
    Kuhle, J.
    Horakova, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 450 - 450
  • [50] Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
    Kusnierova, Pavlina
    Zeman, David
    Hradilek, Pavel
    Cabal, Martin
    Zapletalova, Olga
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (07)